AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 135.4 SEK 0.37%
Market Cap: 16.5B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AddLife AB
Research & Development Peer Comparison

Comparables:
BICO
BIOT
G
GENO
MCAP
M
MAGLE

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Research & Development
-kr97m
CAGR 3-Years
-60%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Research & Development
-kr179m
CAGR 3-Years
-44%
CAGR 5-Years
-18%
CAGR 10-Years
-18%
G
Genovis AB
STO:GENO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is AddLife AB's Research & Development?
Research & Development
-97m SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Research & Development amounts to -97m SEK.

What is AddLife AB's Research & Development growth rate?
Research & Development CAGR 5Y
-38%

Over the last year, the Research & Development growth was -20%. The average annual Research & Development growth rates for AddLife AB have been -60% over the past three years , -38% over the past five years .

Back to Top